<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">351988</id>
  <title nil="true"/>
  <common-name>1-[3-(2-fluorophenyl)-5-[2-[(2-phenyl-1h-indol-3-yl)methylideneamino]phenyl]-3,4-dihydropyrazol-2-yl]ethanone</common-name>
  <description>1-[3-(2-fluorophenyl)-5-[2-[(2-phenyl-1h-indol-3-yl)methylideneamino]phenyl]-3,4-dihydropyrazol-2-yl]ethanone is a chemical compound with the formula C32H25FN4O. With an average molecular weight of 500.60 g/mol, 1-[3-(2-fluorophenyl)-5-[2-[(2-phenyl-1h-indol-3-yl)methylideneamino]phenyl]-3,4-dihydropyrazol-2-yl]ethanone is a heavy molecule.</description>
  <cas>133381-55-2</cas>
  <pubchem-id>3077078</pubchem-id>
  <chemical-formula>C32H25FN4O</chemical-formula>
  <weight>500.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T18:03:03Z</created-at>
  <updated-at type="dateTime">2026-08-31T18:03:03Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(=O)N1C(CC(=N1)C2=CC=CC=C2N=CC3=C(NC4=CC=CC=C43)C5=CC=CC=C5)C6=CC=CC=C6F</moldb-smiles>
  <moldb-formula>C32H25FN4O</moldb-formula>
  <moldb-inchi>InChI=1S/C32H25FN4O/c1-21(38)37-31(24-14-5-8-16-27(24)33)19-30(36-37)25-15-7-9-17-28(25)34-20-26-23-13-6-10-18-29(23)35-32(26)22-11-3-2-4-12-22/h2-18,20,31,35H,19H2,1H3</moldb-inchi>
  <moldb-inchikey>NJPVEXLMFXDVOA-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">500.2012396</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.9</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM347881</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>1-[3-(2-fluorophenyl)-5-[2-[(2-phenyl-1h-indol-3-yl)methylideneamino]phenyl]-3,4-dihydropyrazol-2-yl]ethanone</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Indoles and derivatives</klass>
  <subklass>Indoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0302278</sync-id>
  <structure-inchikey>NJPVEXLMFXDVOA-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>2000000000000000000000000104000000100000000000000000010000000000000000000000800000028000102004000000000000000000000000000100000000088000000000000000000000000020040000000210000004008100000000000000010000000000000080000000000000020100000800000081040000501080000040000000800000200000000000800000000100000000000000400000000018008000000000040000280000000000000000000080000020000000000000000000040000000000000000000000000000000000000000004200000001004000000000008000000060000020000404804000400000000000000000010000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKwAAAIABBgBgAAAAAQMGACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:49:49Z</structure-indexed-at>
</compound>
